FLT3 inhibitors potentially improve response rates in acute myeloid leukemia harboring t(6;9)(DEK::NUP214): the Mayo Clinic experience.

Saved in:
Bibliographic Details
Title: FLT3 inhibitors potentially improve response rates in acute myeloid leukemia harboring t(6;9)(DEK::NUP214): the Mayo Clinic experience.
Authors: Csizmar CM; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN., Saliba AN; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN., Greipp PT; Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN., Alkhateeb H; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN., Begna KH; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN., Foran JM; Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Jacksonville, FL., Gangat N; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN., Hogan WJ; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN., Hook CC; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN., Litzow MR; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN., Mangaonkar AA; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN., Palmer JM; Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Phoenix, AZ., Pardanani A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN., Shah MV; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN., Tefferi A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN., Torghabeh MH; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN., Wolanskyj-Spinner AP; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN., Patnaik MM; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN., Kaufmann SH; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA; Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN. kaufmann.scott@mayo.edu., Al-Kali A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN. alkali.aref@mayo.edu.
Source: Haematologica [Haematologica] 2024 Nov 01; Vol. 109 (11), pp. 3785-3789. Date of Electronic Publication: 2024 Nov 01.
Publication Type: Journal Article
Journal Info: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1592-8721
DOI:10.3324/haematol.2024.285359